Blood pressure self-monitoring in pregnancy (BuMP) feasibility study; a qualitative analysis of women's experiences of self-monitoring by Hinton, L. et al.
              
City, University of London Institutional Repository
Citation: Hinton, L., Tucker, K. L., Greenfield, S. M., Hodgkinson, J. A., Mackillop, L., 
McCourt, C., Carver, T., Crawford, C., Glogowska, M., Locock, L., Selwood, M., Taylor, K. S. 
& McManus, R. J. (2017). Blood pressure self-monitoring in pregnancy (BuMP) feasibility 
study; a qualitative analysis of women's experiences of self-monitoring. BMC Pregnancy and 
Childbirth, 17, 427.. doi: 10.1186/s12884-017-1592-1 
This is the published version of the paper. 
This version of the publication may differ from the final published 
version. 
Permanent repository link:  http://openaccess.city.ac.uk/19073/
Link to published version: http://dx.doi.org/10.1186/s12884-017-1592-1
Copyright and reuse: City Research Online aims to make research 
outputs of City, University of London available to a wider audience. 
Copyright and Moral Rights remain with the author(s) and/or copyright 
holders. URLs from City Research Online may be freely distributed and 
linked to.
City Research Online:            http://openaccess.city.ac.uk/            publications@city.ac.uk
City Research Online
RESEARCH ARTICLE Open Access
Blood pressure self-monitoring in
pregnancy (BuMP) feasibility study; a
qualitative analysis of women’s experiences
of self-monitoring
Lisa Hinton1,4*, Katherine L. Tucker1, Sheila M. Greenfield2, James A. Hodgkinson2, Lucy Mackillop3,
Christine McCourt5, Trisha Carver1, Carole Crawford1, Margaret Glogowska1, Louise Locock6, Mary Selwood1,
Kathryn S. Taylor1 and Richard J. McManus1
Abstract
Background: Hypertensive disorders in pregnancy are a leading cause of maternal and fetal morbidity worldwide.
Raised blood pressure (BP) affects 10% of pregnancies worldwide, of which almost half develop pre-eclampsia. The
proportion of pregnant women who have risk factors for pre-eclampsia (such as pre-existing hypertension, obesity
and advanced maternal age) is increasing. Pre-eclampsia can manifest itself before women experience symptoms
and can develop between antenatal visits. Incentives to improve early detection of gestational hypertensive
disorders are therefore strong and self-monitoring of blood pressure (SMBP) in pregnancy might be one means to
achieve this, whilst improving women’s involvement in antenatal care. The Blood Pressure Self-Monitoring in
Pregnancy (BuMP) study aimed to evaluate the feasibility and acceptability of SMBP in pregnancy.
Methods: To understand women’s experiences of SMBP during pregnancy, we undertook a qualitative study embedded
within the BuMP observational feasibility study. Women who were at higher risk of developing hypertension and/or pre-
eclampsia were invited to take part in a study using SMBP and also invited to take part in an interview. Semi-structured
interviews were conducted at the women’s homes in Oxfordshire and Birmingham with women who were self-
monitoring their BP as part of the BuMP feasibility study in 2014. Interviews were conducted by a qualitative researcher
and transcribed verbatim. A framework approach was used for analysis.
Results: Fifteen women agreed to be interviewed. Respondents reported general willingness to engage with monitoring
their own BP, feeling that it could reduce anxiety around their health during pregnancy, particularly if they had previous
experience of raised BP or pre-eclampsia. They felt able to incorporate self-monitoring into their weekly
routines, although this was harder post-partum. Self-monitoring of BP made them more aware of the risks of
hypertension and pre-eclampsia in pregnancy. Feelings of reassurance and empowerment were commonly
reported by the women in our sample.
Conclusions: SMBP in pregnancy was both acceptable and feasible to women in this small pilot study.
Keywords: Pregnancy, Blood pressure, Self-monitoring, Hypertension, Pre-eclampsia, Qualitative, Women’s
experiences
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Background
Hypertensive disorders in pregnancy are a leading cause
of maternal and fetal morbidity worldwide [1]. Raised
blood pressure (BP) affects 10% of pregnancies
worldwide, of which almost half develop pre-eclampsia
[2]. The proportion of pregnant women who have risk
factors for pre-eclampsia (such as pre-existing hypertension,
obesity and advanced maternal age) is increasing [3, 4].
Pre-eclampsia can manifest itself before women ex-
perience symptoms [5–7] and can develop between
antenatal visits. Incentives to improve early detection of
gestational hypertensive disorders are therefore strong
and self-monitoring of blood pressure (SMBP) in
pregnancy might be one means to achieve this, whilst
improving women’s involvement in antenatal care.
In the general population, SMBP is increasingly popular
with patients, the general public and health professionals.
A recent UK study indicated around a third of people with
hypertension self-monitor BP [8], which is more accurate
for diagnosis and better correlated with cardiovascular
outcome than measurements taken in the clinic [9, 10].
However, few data exist regarding SMBP in pregnancy,
which leaves many unanswered questions about its
acceptability, safety and efficacy: whether women will en-
gage with self-monitoring, whether it will be accurate and
affect pregnancy outcomes, and whether it will increase
feelings of medicalisation and anxiety for women during
their pregnancy [11–14]. Recent research exploring the
acceptability and psychological impact of antenatal screen-
ing for pre-eclampsia has highlighted the potential
positive, negative and unintended effects of providing
screening information for pre-eclampsia [15].
The Blood Pressure Self-Monitoring in Pregnancy
(BuMP) study aimed to evaluate the feasibility and ac-
ceptability of SMBP in pregnancy. This paper reports
the qualitative data collected as part of the feasibility
study and considers it in the context of the increasing
popularity of SMBP in the population at large and the
impact it may have on women’s experiences of their
pregnancy [8, 16] .
Methods
Women who were deemed at higher risk of pre-
eclampsia (who had any of: previous pre-eclampsia, fam-
ily history of pre-eclampsia, hypertension, pregnancy
interval of 10 years, age 40 or over, high BMI, first or
multiple pregnancy, renal disease) according to the
National Institute for Care and Excellence (NICE) guide-
lines [17] were invited at between 12 and 16 weeks in
their pregnancy to take part in a study that asked them
to monitor their own BP at home, in addition to stand-
ard antenatal care through their pregnancy, and for up
to 6 weeks post-partum. Participants self-monitored
their own blood pressure using an automated electronic
sphygmomanometer validated for use in pregnancy and
pre-eclampsia (Microlife WatchBP home). The women
were asked to self-monitor, taking two measurements in
both morning and evening following five minutes rest
on 3 days a week (Monday, Wednesday and Friday).
Women used a traffic light system (red – high BP, ur-
gent action required; amber – raised BP, action required;
green – normal BP) developed from our previous work
to classify raised BP and were given written advice
regarding actions in the light of persistently high read-
ings [18]. Optionally they could text their readings to a
central server and receive automated responses via the
NHS “Florence” Simple Telehealth system [19, 20],
which also provided text prompts and reminders to the
participants.
Interviews
One hundred and seventy women recruited to the BuMP
study provided home readings during their pregnancy.
At study appointments, women were invited by the re-
search midwife to take part in an interview study to find
out more about their experiences of the pilot study, and
their views about SMBP. They were given an informa-
tion pack that included information about the interview
and a reply slip. Fifteen women returned slips (13 from
Oxfordshire, 2 from Birmingham) and interviews were
conducted postpartum with all the women who volun-
teered. Interviewee identifiers after the quotations pre-
sented here relate to the identifiers in Table 1. Those
agreeing to take part in the interviews were representa-
tive of the study population, including a range of ethni-
city, age, demographic area and risk factors used for
inclusion in the study. However, no women who
dropped out of the self-monitoring of blood pressure
study agreed to be interviewed.
Semi-structured interviews were conducted with the
women in their own homes, after they had given birth
and stopped monitoring their BP as part of the study.
The interviews, conducted by an experienced qualitative
researcher with a social science rather than health
professional background (LH) were semi-structured and
included women’s experiences of pregnancy, their
attitudes to self-monitoring and their experiences of par-
ticipating in the BuMP study. Interviews ranged in
length from 30 to 60 min and typically took place be-
tween 3 and 6 months after birth in order that women
had time recover from the immediate birth experience
and to assimilate their pregnancy monitoring experience
but that it was still relatively recent, although some
maternity research indicates there is little recall bias
regarding birth experiences [21]. An interview topic
guide was developed, and refined as interviews were
collected (see appendix for Topic Guide). Interviews
were audio recorded and transcribed for analysis. Initial
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thematic coding and analysis was undertaken by LH. A
framework that included the themes reported here was
developed in collaboration with the multidisciplinary
study team. A Framework analysis was undertaken,
employing five stages (familiarisation with the data,
identifying a thematic framework, indexing, charting and
finally mapping and interpretation) [22]. Interviewing
continued until data saturation was reached for the
themes reported in this paper [23]. Framework analysis
has been developed specifically for applied or policy
relevant qualitative research, and was used in this study
so that specific questions could be asked to inform
future research [24]. In this study, the framework was
not a priori, however, but derived from initial analysis of
the interviews. Ethical approval was provided for the in-
terviews as part of the Narratives of health and illness
for Healthtalkonline 2012.’ IRAS ID 112111, approved
by NRES Committee South Central- Berkshire ref.: 12/
SC/0495.
Results
Overview
Of the 15 women interviewed, 10 were in their first
pregnancy, five had previous experience of high BP or
pre-eclampsia or family history of pre-eclampsia, two
had age 40 or over at the time of the study, six had high
BMI, one had pregnancy interval of over 10 years and
one had multiple pregnancy. None of the women devel-
oped pre-eclampsia, although three were diagnosed with
hypertension (>140/90 mmHg) (see Table 1).
Women who took part were willing to engage with
monitoring their own BP, feeling that it could reduce
some of the anxiety around their health during preg-
nancy. They felt able to incorporate self-monitoring into
their weekly routines, although keeping up with the
monitoring once they had stopped work and lost that
daily routine could be harder and it was particularly
hard after the baby was born.
Being involved in the study made women more aware
of the risks of raised BP and pre-eclampsia. Many felt
reassured and empowered, particularly if they had previ-
ous experience of the disease.
Detailed analysis
The framework analysis interrogated the interview data
across five themes which themselves had emerged from
early stages of analysis [21].
1. Women’s attitudes to their health
2. SMBP as reassuring not anxiety provoking
3. Understanding of the trial, BP and risks
4. Experiences of pregnancy and identifying raised BP
5. Practicalities of SMBP
Table 1 Qualitative interview sample
Interviewee No Ethnicity Age * Reason/s for inclusion Diagnosis of Hypertension IMDa Highest Qualification
1 White British 42 Age, BMI, hypertensive in previous pregnancy,
PE in previous pregnancy
No 1 First Degree
2 White British 29 First pregnancy, hypertensive before pregnancy Yes, CH, GH 7 GCSE, O Level or CSE
3 Pakistani 23 First pregnancy No 2 First Degree
4 White Other 40 BMI, an inter-pregnancy interval of >10 years
previous (previous early miscarriage)
No 5 Professional qualification
5 White British 33 Family history of PE, hypertensive in previous
pregnancy
No 9 Post-graduate or above
6 White British 33 First pregnancy No 5 First degree
7 White British 38 First pregnancy, BMI No 7 First degree
8 White British 27 First pregnancy, multiple pregnancy No 8 First degree
9 unknown 31 First pregnancy, BMI No 1 unknown
10 African 35 BMI No 5 First degree
11 White British 36 Family history of PE, Previous hypertension,
hypertensive in previous pregnancy
Yes, CH 10 Professional qualification
12 White British 30 First pregnancy No 10 Post-graduate or above
13 White British 34 Hypertension in previous pregnancy Yes, CH 4 First degree
14 White British 40 Age, first pregnancy No 7 Post graduate qualification
15 White British 35 BMI, first pregnancy No 10 Professional qualification
*Age at the time of interview
aIndex of Multiple Deprivation
IMD – Index of Multiple Deprivation; Department for Communities and Local Government. English indices of deprivation
2015. http://imd-by-postcode.opendatacommunities.org/
CH Chronic hypertension, GH Gestational hypertension, PE Pre-eclampsia
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Women’s attitudes to their health
Women who took part in the interviews described
being generally quite relaxed about their health. It
was not something they worried about normally,
although some said they were aware of their diet,
exercise and general health during their pregnancy.
Some of the women who were in their first pregnancy
or included because of a higher BMI were somewhat
surprised and resentful of being labelled at higher
risk.
“Despite being kind of singled out because of my age
and my weight that I was high risk for preeclampsia,
actually, my blood pressure was perfect all the way
through” (04).
But many women, in particular, those women who
had previous experience of raised BP or pre-
eclampsia, were understanding of the risks and felt
happy to be included.
“You don’t have to wait until the last minute so it
was a great opportunity and I was very pleased to
accept.” (10).
Participants were generally happy to engage with self-
monitoring. It was described as convenient and a good
opportunity to look after their health.
“Having that opportunity to make sure everything is all
right because you just don’t know what’s going on, do
you, inside.” (13).
SMBP as reassuring not anxiety provoking
Women were asked if testing their BP during
pregnancy made them feel more or less anxious. It
was acknowledged that thinking about their BP could
make them fearful as it might be raised when they
measured it. But more commonly women said they
were “reassured” by self-testing and regarded it as a
good opportunity to keep an eye on themselves.
“I think it was peace of mind for myself because pre-
eclampsia can happen to me with, you know, given, you
know, there’s no reason why it wouldn’t have, couldn’t
have happened to me. So again, it was just the nice [um]
nice reassurance.” (07).
“It makes you more anxious because it’s higher but
it’s reassuring because you know you can do something
about it. And that’s good because I didn’t feel any
different.” (08).
“Less anxious, so much less anxious. Yeah so much
less.” (13).
Women were asked what their partners and family
thought about their participation in the study. While
one respondent said that their partner expressed
concern that it was raising her anxiety, most women
described their partners as supportive of their self-
monitoring.
Some women described feeling empowered, particu-
larly if they had had a previous experience of raised BP
or pre-eclampsia.
“A good opportunity to take a little bit of control of
your health” (06).
“Because I’m scientific and a little bit nosy about these
things and, you know, I was looking forward to it for my
own interest but I found it very reassuring and also very
empowering.” (14).
Having access to their own readings also gave women
the opportunity to reassure themselves if they felt unwell
at any stage during their pregnancy. Participant 14 was
in her first pregnancy and an older mother:
“Because, at various points, I thought, I don’t feel very
well [um] and I thought, I’ll just take my blood pressure
and it was fine and it was exceptionally reassuring that
to, be able to do that yourself and know that you’re
okay.” (14).
Some participants experienced headaches and the
monitoring was able to reassure them that they were
not related to BP. Participant 11 had high BP with
her first pregnancy and was a migraine sufferer, so
she was happy that she could test herself if she
started to feel unwell.
“So I didn’t want to be worrying all the time that, “Oh
my god, I’ve got a headache. Is it my blood pressure?” At
least, with having the monitor at home, I could double
check for myself and that’s really, what, why I wanted to
take part.” (11).
Participant 05 took part in the study during her
second pregnancy. She had pre-eclampsia during her
first.
“I was happy to do it and, like I said, there were times
when I thought it was probably going to be beneficial as
well for my own peace of mind. I kind of, there was a
couple of times when I had a headache and it would
have been something that I perhaps would have, eventu-
ally, gone to a GP about [um] to get it resolved and just
knowing that I was going to be testing my blood pressure
either that day or the following day. And it just reassured
me a little bit that [um] that it would be all right.” (05).
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Understandings of the study, BP and risks of high BP in
pregnancy
Participating women seemed to have a clear understand-
ing of the aims of the trial. One woman was clearly
aware that pre-eclampsia could develop rapidly and
therefore felt it was good for women to measure their
own BP:
“In such a condition, every minute is important” (03).
Some women had previous experience of pre-eclampsia
so were aware of the risks. Others had just a vague under-
standing of the condition and its symptoms, but under-
stood that it was important.
“It increased my awareness of the potential conditions I
could suffer from, and I thought that was a very positive
thing.” (14).
While most understood that the trial was trying to
improve the early detection of pre-eclampsia, some
would have liked more information about the condition.
Participant 14 wanted to understand what pre-eclampsia
was and more about why it was important to do the work.
I think it took me a while to actually understand what
preeclampsia was. I think there could have been more in-
formation about what preeclampsia was as a condition
and how it affected women and, therefore, why it was im-
portant to do this work. (14).
Consistent with other qualitative research into the mo-
tivations behind trial participation [25] women described
their motivations for agreeing to take part in the trial as
two-fold; being able to help others (through research)
and at the same time helping themselves. Women who
had already experienced pre-eclampsia were especially
keen to participate, seeing SMBP as a way of offering
peace of mind and keeping themselves safe during their
pregnancy.
“I’d rather know my blood pressure than not know it.
[um] And it was a way of keeping safe. It felt like that
anyway to me.” (09).
“An opportunity to contribute my own little portion” (10).
Women said they found the timetable of the trial easy
to understand and that it was clear to them what to do/
who to call if their BP was raised.
The pregnancy and identifying raised BP
Most women remained well throughout their pregnan-
cies, and for most self-monitoring did not detect any
raised BP and therefore had no discernible effect on the
course of their pregnancy. However raised BP was
picked up in a small number of women.
Participant 01 took part in the study during her sec-
ond pregnancy. She had developed gestational diabetes
and gestational hypertension in her first pregnancy.
Home BP monitoring identified raised BP after her son
was born. She spoke to her midwife, who identified that
she needed to stop taking the ibuprofen she had been
prescribed, as it is not recommended after 30 weeks ac-
cording to NICE guidelines.
“It was picked up because I was doing the study that I,
that they realised that my blood pressure was elevated
and I actually needed to come off ibuprofen because it
wasn’t safe for me to stay on it and I wouldn’t have
known that.” (01).
Participant 02 was pregnant with her first baby, and
raised BP was detected from 12 weeks. She was hospita-
lised several times for BP observations and finally
induced 3 weeks early. She was pleased she was self-
monitoring her BP as she did not feel unwell even
though her readings were high.
“Yeah, sometimes it was a real shock. You’d just be lay-
ing there and they’d take your blood pressure and, yeah,
it’d be really high.” (02).
Participant 11 was a migraine sufferer, who had also
had previous high BP. She had a couple of spikes of
raised BP but it came down the next day. She was reas-
sured by SMBP. Participant 08 was also relieved to be
self-monitoring. At the end of her twin pregnancy her
BP readings were high.
“I found that really, really helpful because you can
think, because I felt fine but if you’ve got high blood
pressure, and I did it a couple of times extra just to make
sure it wasn’t just that one time and it was a bit high
but [um] there wasn’t there wasn’t anything to worry
about, which was good, but it was really nice to have
that reassurance.” (08).
Participant 13 knew that she suffered from white coat
hypertension (that is her BP was higher when measured
in the clinic than otherwise), so she was very pleased to
be able to take her BP herself.
“From my perspective, I got a little machine to bring
home and just from a, from an obsessive compulsive, you
know, perspective of that blood pressure I was like, yeah,
great, I get to do it three times a week and know that I’m
okay and having that confidence that actually, my blood
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pressure was okay so if I went to the hospital, I could get
out the book and say, it’s not, it’s not me. It’s because I’m
here that it’s a little bit elevated.” (13).
Most women found their health professionals sup-
portive of their self-monitoring and involvement in
the study, but this was not always the case. Partici-
pant 09 was frustrated that she was forced to do 24-h
ambulatory blood pressure monitoring (ABPM) after
raised BP was picked up during a hospital visit. She
felt that health professionals were dismissive of her
readings.
“And they wouldn’t listen to me that I’d done the trial,
I had my folder there, I said, “Look, everything has been
fine. I did it two days ago, it was fine. I did it this morn-
ing, it was fine.” But they wouldn’t listen to me”. (09).
Practicalities of SMBP
There were varying experiences of fitting SMBP into
daily life. Most women admitted to forgetting to take
their BP at various stages, but described the different
strategies they developed to remember and make it
part of their daily routine. Participant 04 was an IT
consultant who worked at home a lot. She set re-
minders on her computer calendar. Participant 05
found it hard with a young child and while still at
work. Her husband did more of the early morning
childcare and she set reminders on her phone for
7 am and 7 pm. Once women had established a rou-
tine for themselves they found it quite easy to re-
member and incorporate into daily life. But if that
routine was disrupted (if they were away for work or
on holiday, or after the birth of their baby), it was
much harder to remember.
Not all women had signed up for the “Florence”
text message system used in the study, which pro-
vided reminders and enabled women to submit their
readings easily. Some really liked it; one commented
she had “baby brain” (01) so appreciated the re-
minders.
“Because even though you think taking your blood
pressure three times a week, twice a day in those three
times a week, you’d think, oh it was easy to remember
but, when you’re juggling work and being pregnant and
having a bit of pregnancy brain as well, it was just trying
to remember all of these things and just a little nudge
every morning was good to have it.” (07).
Others opted out of the “Florence” text system,
finding the messages irritating because they came at
the wrong time.
“Yeah, they were irritating because at a moment, I’d
get three to four messages and I send my readings then
then I got another message.” (03).
Women had varying experiences of how long it took
to take their BP. Some said it took a good 20 min each
time, as it was important to rest before they took the
readings. Others felt it only took a couple of minutes
morning and evening. As participants were advised of
the need to have five minutes rest before taking BP
measurements, this may reflect a need for enhanced
training.
The role and reassurance offered by the research
midwife was a recurrent theme. Many women liked
having access to another health professional and
appreciated the extra support, reassurance and infor-
mation that the research midwife was able to give
them.
“I feel like it is an extra gift for me to have extra
help and extra advice and an extra person to look
after you.” (03).
“Yeah, if anything she’s become more of a, she’s more of
a a rock to me than my midwife was, so she was, I was
always, we were always on the phone to each other. If
ever I had any worries, I’d call [research midwife] rather
than my midwife.” (07).
Generally, women did not feel they were making
extra appointments to take part in SMBP or the
study. They appreciated being able to see the research
midwife when they were at regular antenatal appoint-
ments so they did not need to take extra time off
work.
Participant 03 was recently arrived from Pakistan and
felt isolated when her husband was at work. She said
that if the research midwife had not visited she would
not have taken part, as it would have meant extra doc-
tors’ visits that her husband would have to take time off
for. However one woman (from Birmingham) felt that
she missed out because on at least one of her appoint-
ments she saw the research midwife rather than the
community midwife.
In terms of location, offering the opportunity to moni-
tor at home was popular with women who knew they
were affected by white coat hypertension. They were
much happier doing it themselves.
“I felt a lot more in control of the surroundings in
which I was having it done. So I felt comfortable. I
didn’t feel as if I was automatically going to get a
high reading because I can I can honestly talk myself
into a high blood pressure reading, I’m sure of it.”
(13).
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Discussion
Main findings
Our findings indicate that women participating in this
qualitative study were willing to engage with SMBP, and
that it could reduce anxiety around their health during
their pregnancy. Although there was some variation in re-
sponses depending on whether women perceived them-
selves as high risk, many of the women interviewed felt
reassured and empowered by SMBP, particularly if they
had previous experience of pre-eclampsia. Women felt
able to incorporate the monitoring into their weekly rou-
tines, with some adjustments, although this was more
challenging in the post-partum period. The respondents
felt that being involved in the study made them more
aware of the risks of raised BP and pre-eclampsia.
Strengths and limitations
This study included women with a range of ages, social
circumstances and previous experiences including those
with a previous history of pre-eclampsia and those sim-
ply at higher risk. However, it cannot be certain how far
findings apply to women at higher risk of pre-eclampsia
in general. We do not have insights from those who de-
clined to be in the BuMP study at all, or women who
withdrew, or from women who participated but did not
respond to the interview invitation. Participants were
generally White British, educated to degree level and
may not be representative of the wider population.
There was also an imbalance in numbers between
women from Oxford and Birmingham, so the experi-
ences from both sites were not equally represented. The
supportive role of the research midwife in the Oxford
sites was highlighted as a major factor in the success of
the pilot in that location, but in Birmingham staffing
changes were required due to ill health. However, this
qualitative work with a small sample does provide
valuable information to inform future research. The self-
monitoring regime tested in the pilot study was feasible
and acceptable to women, offering reassurance and
empowerment. The qualitative component of the full
trial will explore how far these findings may be general-
isable to a more diverse range of women. This study
included 15 women but given the relatively focused
nature of the research questions, data saturation was
reached (i.e. no new data on these themes emerge in the
last few interviews) suggesting that the conclusions
would not have been altered by a larger sample size. [23]
Nonetheless, further research will enable us to assess
whether further issues would be identified with a larger
and more diverse sample.
Interpretation
We are mindful that this research takes place amidst de-
bates around the medicalisation of maternity care [26–29]
and the complexities of articulating risk (for mother and
baby) in contemporary childbirth practice [12]. However,
the wider context of self-care and self-monitoring having
the potential to enhance care, self-efficacy and empower-
ment should be acknowledged [30–33].
In terms of motivations and adherence to self-
monitoring, the results from this study are similar to
other trials of SMBP in the general population [34] and
self-monitoring in other conditions such as asthma and
diabetes [35–37]. However, this is the first qualitative
study that authors are aware of regarding women’s expe-
riences of self-monitoring their BP in pregnancy.
Women in pregnancy are making decisions about both
their own health and their baby’s health, which makes
this a different experience from SMBP in the general
population. Women with previous experience of pre-
eclampsia are often not fully aware of their risks of
hypertensive and cardiovascular problems in subsequent
pregnancies or outside pregnancy [38].
Pregnancy is an anxious time for some women, even
during a normal antenatal period and labour, in part
generated by fears and uncertainty about the outcome
[39]. Studies of women’s anxiety levels during labour
and how they are affected by additional fetal monitoring
[40] have shown that women can be reassured by active
monitoring. Although the very use of fetal monitoring
can imply birth is a risky process needing careful
monitoring, women appeared reassured. It has been ar-
gued that asking women to monitor their BP will also
raise their anxiety: a study of women who were offered
screening for pre-eclampsia found that the screening
process changed the way that women regarded their
pregnancy, shifting it from a normal life event to
something to worry about [15]. This was not born out
by our findings, but our study focused on women identi-
fied with a higher risk of pre-eclampsia, according to
NICE guidelines. As with patient experiences of SMBP
outside of pregnancy, women gained knowledge, engage-
ment and confidence in taking control of their own care
[29, 34, 41, 42].
There is a potential concern that while SMBP might
give women the opportunity to reassure themselves;
this could be false in the case of pre-eclampsia with
normal blood pressure. A potential learning point
from this pilot study is that women should be given
more education around pre-eclampsia and its symp-
toms and indeed several reported they would find this
helpful. Several women described feeling reassured by
normal BP in the context of feeling unwell but should
be aware of the potential importance of other symptoms
regardless of BP. These additional educational messages
will be tested in a larger forthcoming trial, which will also
assess outcomes with respect to timing of detection of
pre-eclampsia.
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As the availability and acceptability of SMBP increases
[16], it is perhaps interesting to think of self-monitoring
practices as adding to the cultural props that women
can draw on during a time of anxiety. Machin and
Scammell’s (1997) ethnographic work [43] on experi-
ences of labour (using a ritual theory approach, explor-
ing pregnancy and birth as a rite of passage), found that
women relied upon and were reassured by the medical
model of childbirth because that was the cultural tool
offered to them. This could potentially be the case for
self-monitoring and will be explored further in the quali-
tative component of the trial.
Using digital health solutions, such as mobile phone
text monitoring, for the detection and management of
medical conditions in pregnancy is a rapidly develop-
ing area of research. Technologies under investigation
include SMBP, self-testing of blood sugar in women
with gestational diabetes and self-testing for protein-
uria [44–47]. Self-monitoring and self-testing com-
bined with digital technology may detect problems
earlier and engage patients in their care, providing
rapid feedback to improve clinical management and
allow electronic capture of data. This work shows
that the development of home monitoring and testing
for raised blood pressure is likely to be acceptable to
many women at higher risk.
Conclusion
This pilot work has found that SMBP during pregnancy is
acceptable to women who are categorised as at higher risk
of pre-eclampsia in pregnancy, and can be empowering
and educative, but we still need to know more about
women’s experiences of self-monitoring in pregnancy and
the acceptability to a more socio-economically and ethnic-
ally diverse range of women. If self-monitoring becomes
the norm and perhaps replaces professional monitoring in
some circumstances, will it impact on the relationship and
interactions women have with their health professionals
during their pregnancies? Interventions can work in some
places and settings, and not others, and have unintended
consequences [48]. We plan to test the effectiveness of
SMBP during pregnancy in a larger trial and also to explore
the mechanisms for how SMBP might or might not work
in conjunction with existing antenatal care, the barriers and
facilitators to SMBP, and how bringing self-care into the
home might impact on women’s experiences of pregnancy.
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